Bioceres Crop Solutions Corp. (BCBA:BIOX)
Argentina · Delayed Price · Currency is ARS | Market Cap | 21.73B -88.2% |
| Revenue (ttm) | 352.30B -38.0% |
| Net Income | -69.48B |
| EPS | -1,139.50 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 286,300 |
| Open | 347.00 |
| Previous Close | 379.25 |
| Day's Range | 343.00 - 387.50 |
| 52-Week Range | 362.00 - 3,162.50 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |
About Bioceres Crop Solutions
Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, comm... [Read more]
Financial Performance
In fiscal year 2026, Bioceres Crop Solutions's revenue was $237.80 million, a decrease of -28.66% compared to the previous year's $333.34 million. Losses were -$46.90 million, -15.37% less than in 2025.
Financial numbers in USD Financial StatementsNews
Bioceres Crop Solutions Earnings Call Transcript: Q4 2026
Fiscal 2026 saw an 18% revenue decline due to litigation and business restructuring, but cost reductions led to improved adjusted EBITDA and stabilization in core segments. The company targets 40% gross margins and further SG&A reductions, with ongoing focus on liquidity and legal matters.
Bioceres Crop Solutions Slides: Q4 2026
Bioceres Crop Solutions has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on September 15, 2026.
Bioceres Crop Solutions Earnings release: Q4 2026
Bioceres Crop Solutions released its Q4 2026 earnings on September 15, 2026, summarizing the period's financial results.
Bioceres Crop Solutions Annual report: Q4 2026
Bioceres Crop Solutions has published its Q4 2026 annual report on September 15, 2026.
Bioceres reports Q4 adjusted EBITDA $0.6M vs. ($9.6M) last year
Reports Q4 revenue $55.9M vs. $55.4M last year. Mr. Federico Trucco, Bioceres (BIOX)’ Chief Executive Officer, commented: “Fiscal 2026 was a challenging year for Bioceres, marked by the ongoing litiga...
Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2026 Financial and Operating Results
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricul...
Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2026 Financial Results Conference Call on Tuesday, September 15, 2026 at 8:30 a.m. Eastern Time
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to...
Bioceres Crop Solutions Earnings release: Q2 2026
Bioceres Crop Solutions released its Q2 2026 earnings on June 2, 2026, summarizing the period's financial results.
Bioceres Crop Solutions Earnings Call Transcript: Q3 2026
Fiscal Q3 2026 saw a 23% revenue decline and a $10 million net loss, driven by lower gross profit and the impact of the ProFarm foreclosure, which resulted in a $179 million non-cash loss. Management is focused on liquidity, legal disputes, and streamlining operations.
Bioceres Crop Solutions Slides: Q3 2026
Bioceres Crop Solutions has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on May 12, 2026.
Bioceres Crop Solutions Earnings release: Q3 2026
Bioceres Crop Solutions released its Q3 2026 earnings on May 12, 2026, summarizing the period's financial results.
Bioceres reports Q3 operating profit $4.3M vs. ($4.3M) last year
Reports Q3 revenue $39.4M, one estimate $54.5M. Mr. Federico Trucco, Bioceres (BIOX)’ Chief Executive Officer, commented: “This quarter reflects a period of transition and operational refocusing for t...
Bioceres Crop Solutions Reports Fiscal Third Quarter 2026 Financial and Operational Results
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricul...
CORRECTING and REPLACING Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time
ROSARIO, Argentina--(BUSINESS WIRE)--The dial-in details of release dated May 4, 2026 have been revised. The US Toll Free dial-in number should read 1-833-461-5787; the International dial-in numbers l...
Bioceres Crop Solutions to Host Fiscal Third Quarter 2026 Financial Results Conference Call on Tuesday, May 12, 2026 at 8:30 a.m. Eastern Time
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to...
A Message from Our Chief Executive Officer
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX): Dear Fellow Shareholders, This communication accompanies the filing of our Form 6-K for the second quarter of fiscal ...
Bioceres price target lowered to $2 from $2.25 at Canaccord
Canaccord analyst Austin Moeller lowered the firm’s price target on Bioceres (BIOX) to $2 from $2.25 and keeps a Hold rating on the shares. On December 18, New York’s Supreme…
Bioceres announces appointment of Ezequiel Simmermacher as CFO
Bioceres (BIOX) Crop Solutions announced the appointment of its Chief Financial Officer and changes to the composition of the board of directors of the company. Ezequiel Simmermacher is being appointe...
Bioceres price target lowered to $2.25 from $2.50 at Canaccord
Canaccord lowered the firm’s price target on Bioceres (BIOX) to $2.25 from $2.50 and keeps a Hold rating on the shares. The firm reported lower Q1 revenues and adjusted EBITDA.
Bioceres Crop Solutions Earnings Call Transcript: Q1 2026
Revenue fell 17% year-over-year to $77.5 million, but gross margin expanded to 47% and adjusted EBITDA rose 61% due to cost reductions. Segment margins improved, though seed and crop protection revenues declined. Net debt remained stable amid ongoing debt dispute.
Bioceres Crop Solutions Earnings release: Q1 2026
Bioceres Crop Solutions released its Q1 2026 earnings on November 13, 2025, summarizing the period's financial results.
Bioceres Crop Solutions Slides: Q1 2026
Bioceres Crop Solutions has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on November 13, 2025.
Bioceres Crop Solutions Reports Fiscal First Quarter 2026 Financial and Operational Results
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ: BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricul...
Bioceres Crop Solutions to Host Fiscal First Quarter 2026 Financial Results Conference Call on Thursday, November 13, 2025 at 8:30 a.m. Eastern Time
ROSARIO, Argentina--(BUSINESS WIRE)--Bioceres Crop Solutions Corp. (NASDAQ: BIOX) (“Bioceres” or the “Company”), a leader in the development and commercialization of productivity solutions designed to...
Bioceres downgraded to Perform from Outperform at Oppenheimer
Oppenheimer downgraded Bioceres (BIOX) to Perform from Outperform without a price target The firm believes the company’s portfolio recapitalization “now appears incrementally challenging.” Bioceres is...